Click here to read a text-only version of this infographic
Strategy Performance Report: Q1-Q4 Fiscal Year 2022-2023 Results
Strategic Direction 1: Personalized and Precise Treatments
- Number of Personalized and Precise Treatment (PPT) clinical volumes
Cancer Ablation Therapy (Interventional Radiology): 549 (Target ≥ 450)
Focused Ultrasound: 25 (Target ≥ 24) - Number of patients enrolled in new clinical trials
Number of Odette patients enrolled in new clinical trials: 25 (Target ≥ 16)
Strategic Direction 2: Integrated and Sustainable Models of Care
- Number of patients receiving specialized/ complex care within select clinics
Jennifer Tory Trauma Clinic: 1,747 (Target ≥ 880)
Vascular Limb Preservation Program: 52 (Target ≥ 103)
Patients enrolled in Congestive Heart Failure Clinic: 97 (Target ≥ 84) - Number of patients treated/referred in collaborative initiative and improved outcome due to collaborative initiative
Referrals of ED chest pain to KMH Cardiology Centres: 607 (Target ≥ 634)
Number of new patients in Rapid Access Addiction Medicine (RAAM) clinic (both locations): 88 (Target ≥ 108)
ED One Team Consults resulting in a return to ED within 7 days: 6.1% (Target < 6.8%)
Strategic Direction 3: Improve Quality and Create a Better Care Experience
- Percent of patients with demographic data collected in new areas across the organization by March 2023
29% (Target ≥ 38%) - Number of virtual health patient visits
Virtual ED visits: 1,097 (Target ≥ 750)
Family Navigation Project: 385 (Target ≥ 373)
Strategic Direction 4: High Performing Teams
- Number of staff trained/mentored on Equity, Diversity & Inclusion (EDI) within Sunnybrook:
316 (Target ≥ 150) - Number of team simulations, both within Sunnybrook and via Outreach:
399 (Target ≥ 265)
Illustrating progress: a patient story
As a former broadcaster, David Onley has always prided himself on the strength of his voice. He had also served as Ontario’s 28th Lieutenant Governor, living a very public life. But in 2017, he started noticing a steep and rapid decline in his health and functioning. His voice weakened, and he nearly drowned in his bathtub because of his declining physical state.
Following a series of tests at Sunnybrook, a brain tumor the size of an orange was detected. David had immediate surgery to remove this non-cancerous meningioma, and then was advised to receive follow up radiation through the MOMENTUM study. The study focuses on a technology called the MR-Linac Elekta Unity, the first machine in the world to combine radiation and high-resolution MRI imaging. It’s a huge advance in precision as it allows the clinical team to see the tumor each day before it’s treated.
Dr. Arjun Sahgal, radiation oncologist and head of the Cancer Ablation Therapy Program, says being able to see the tumor each day results in a change in the medicine or actual radiation treatment plan thirty to forty percent of the time.
David underwent daily treatments that were given over several weeks. He says he took time to learn about the MR-Linac, and the precision of this approach gave him a lot of comfort. He says he’s once again stepping into the public eye by sharing his story, hoping it will help raise awareness for others.
David Onley says he took the time to learn about the MR-Linac technology before his treatments. “I would rather go for something that was being seen effectively live. That’s totally amazing. This is an incredible piece of machinery.”
